海福德集團(00442.HK)擬攜手新寶珠寶成立合營 從事線上珠寶銷售業務
格隆匯12月17日丨海福德集團(00442.HK)公吿,於2021年12月16日,公司與新寶珠寶訂立合營協議,據此,訂約方同意成立合營公司,以從事於線上向中國內地銷售珠寶。
新寶珠寶為於香港註冊成立的有限公司,並主要從事珠寶設計及製造,且其於國際市場上在線上銷售珠寶方面具有良好聲譽。
集團一直積極探索將其銷售業務擴張至直接向中國內地客户銷售的可能性。鑑於成立合營公司乃基於訂約各方"優勢互補、互相支持、長期合作及共同發展"的原則,且最終目的是進軍中國內地的線上珠寶市場,董事(包括獨立非執行董事)認為成立合營公司是集團的戰略性舉措。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.